Perioperative Pain Management for Median Sternotomy in a Patient on Chronic Buprenorphine/Naloxone Maintenance Therapy: Avoiding Opioids in Patients at Risk for Relapse.
Emmanuel AlaladeJena BilinovicAna Gabriela WalchCandice BurrierChristopher MckeeJoseph TobiasPublished in: Journal of pain research (2020)
The opioid crisis in the United States has been pandemic. As such, anesthesia providers are frequently faced with patients who have a history of opioid abuse or are currently receiving chronic therapy for such disorders. The chronic administration of medications such as buprenorphine-naloxone can impact the choice of perioperative anesthesia and pain control. Furthermore, the postoperative administration of opioids may lead to relapse in patients with a history of opioid abuse. We present a 26-year-old male with a history of opioid abuse on maintenance therapy with buprenorphine-naloxone, who presented for median sternotomy, cardiopulmonary bypass, and pulmonary valve replacement. The perioperative implications of buprenorphine-naloxone and implementation of multimodal analgesia are discussed, along with options to decrease or eliminate the perioperative use of opioids.
Keyphrases
- pain management
- chronic pain
- patients undergoing
- end stage renal disease
- ejection fraction
- cardiac surgery
- newly diagnosed
- chronic kidney disease
- public health
- peritoneal dialysis
- healthcare
- aortic stenosis
- coronavirus disease
- pulmonary hypertension
- aortic valve
- aortic valve replacement
- patient reported outcomes
- spinal cord
- atrial fibrillation
- transcatheter aortic valve implantation
- intimate partner violence
- bone marrow
- smoking cessation
- acute kidney injury
- decision making